NEW YORK, Sept. 5, 2013 /PRNewswire-iReach/ -- Clinilabs, a contract research organization that provides early-phase and specialty clinical drug development services to industry, announced today that they will sponsor the American Diabetes Association's (ADA) Step Out: Walk to Stop Diabetes this September. The event is held every year in an effort to raise money for Diabetes awareness.
Diabetes is a serious illness that affects roughly 10% of the population. The disease can cause several complications, including stroke and heart attack, which result in over 200,000 diabetes related deaths a year. As a leading specialty contract research organization (CRO), Clinilabs understands the impact of the high prevalence of diabetes in our country, and is determined to help the American Diabetes Association (ADA) support research that will lead to better treatments for this disease. Lead Recruiter, Carrie Sorkin, acknowledges the importance of taking part in Step Out by stating "as an organization that is heavily involved in clinical care and drug development, we see first-hand the effect that diabetes has on our patients. Because of this, we feel that it is our responsibility to do our best to raise awareness about the health implications of this terrible disease."
The Step Out: Walk to Stop Diabetes event is conducted every year in over 125 locations nationwide. For over 20 years the ADA, along with thousands of volunteers, has helped raise over $175 million for Diabetes research. This year, over 120,000 participants, along with the Clinilabs team, are expected to raise $2 million in New York State events alone.
Clinilabs will sponsor three of the New York walks, taking place in Manhattan, Yonkers, and Long Island on September 28th and 29th. Walkers can visit the Clinilabs booth for free prizes, educational materials, clinical consultations, and information on participating in clinical trials for diabetes. All walkers who visit the Clinilabs booth will have a chance to win a ZEKI tablet. If you or anyone you know is interested in participating or would like to learn more about Diabetes, visit the American Diabetes Association's website at www.diabetes.org.
About Clinilabs Inc.
Clinilabs is a full-service contract research organization (CRO) that specializes in early-phase studies, from first-in-human to proof-of-concept, with normal healthy volunteers and patient populations. The company owns and operates two Phase I units in the US, and maintains a network of highly qualified investigator sites for multicenter Phase II studies Worldwide. Specialty projects, including pharmacodynamic, biomarker, cardiac safety, sleep/wakefulness, Diabetes/metabolic and Japanese bridging are among our strengths. Clinilabs is recognized globally as a leading specialty CRO, offering an alternative to large CROs for specialty projects. For more information, please visit www.clinilabs.com.
Media Contact: Hannah DAoust, Clinilabs, 646-215-6480, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com